This Notice was RESCINDED on July 23, 2018, please see NOT-OD-18-197 that replaces it.
RESCINDED - This Notice was RESCINDED on July 23, 2018, please see NOT-OD-18-197 that replaces it.
SPECIAL EXCEPTION – SUBMISSION OF A3 APPLICATIONS DURING CENTER FOR
SCIENTIFIC REVIEW (CSR) REORGANIZATION
RELEASE DATE: September 22, 2003
National Institutes of Health (NIH)
Present NIH policy allows consideration of revised applications for
only two additional versions (A1 and A2). The policy
was established following analysis of data indicating that
investigators who receive initial funding for an amended application
have a lower success rate in obtaining support for a follow-on
competing application. The likelihood of subsequent success decreased
with an increasing number of amendments. After three reviews, it was
felt that it was time for investigators to take a fresh approach to
their research proposals.
The most common situation is for revised applications to be reviewed by
the same committee that reviewed the previous version, but this is not
always the case. Because of the reorganization of Integrated Review
Groups and their component study sections in the Center for Scientific
Review at NIH, some investigators may be concerned that amended
applications may be assigned to a new study section. This
reorganization is a special circumstance that warrants offering
applicants in a particular category an additional review opportunity.
Accordingly, NIH has decided to allow a third (A3) revision for
applications that meet all of the following criteria:
o They were reviewed in their first revision (A1) in a to-be-disbanded
study section and not funded.
o They were reviewed in a newly created study section as the second
revision (A2) and not funded.
o A note citing this opportunity appears on the summary statement of A2
This will allow all amended applications to have their final two
reviews within the reorganized CSR review committees. This
opportunity applies only to the identified applications; other A3
applications will not be accepted for review consistent with NIH policy
as stated above.
For questions, please contact:
Division of Receipt and Referral
Center for Scientific Review
301-435-0715; 301-480-1987 (fax)